Linking Lipoxygenases with Essential Fatty Acids and Epidermal Barrier Formation

将脂氧合酶与必需脂肪酸和表皮屏障的形成联系起来

基本信息

  • 批准号:
    8906464
  • 负责人:
  • 金额:
    $ 35.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this application is to elucidate the roles of two lipoxygenase (LOX) enzymes and their essential fatty acid (EFA) substrate in forming the water impermeable barrier of the epidermis, defects in which result in ichthyoses and contribute to atopic dermatitis. 12R-Lipoxygenase (12R-LOX) and Epidermal Lipoxygenase-3 (eLOX3) are the only human lipoxygenases that, if mutated to inactive forms, result in a disease, a form of autosomal recessive congenital ichthyosis (ARCI). The fact that the characteristic scaly skin of ARCI is also manifest in essential fatty acid (EFA) deficiency, suggests a possible substrate-enzyme relationship between EFA and the two LOX enzymes. We will test a new hypothesis that connects EFA, 12R- LOX and eLOX3, and the structure of the epidermal water barrier. We propose that the two lipoxygenases oxygenate a critical form of EFA, linoleate esterified to the omega-hydroxyl of the very long chain fatty acid of the unique epidermal acylceramides. We further propose that this oxygenation is required to facilitate hydrolysis of the (oxidized) linoleate moiety and leave the very long chain fatty acid omega-hydroxyl free for coupling to the cross-linked proteins of the corneocyte envelope, a vital step in sealing the water barrier. The Specific Aims are (1) To characterize 12R-LOX and eLOX3 activity in the epidermis in vivo using animal models, (2) To assess the efficacy of LOX products and ceramides in rescuing the phenotype in murine LOX-/- models, (3) To characterize 12R-LOX and eLOX3 activity in human epidermis including in ARCI patients, and (4) To characterize the putative oxidant-sensitive step of acylceramide ester hydrolysis. The results of this study wil piece together an important facet of construction of the epidermal water barrier and allow a rational approach to the use of oxidized linoleate and its analogs for future therapeutic interventions in the LOX- dependent classes of ichthyoses. If the physiology of the barrier is properly understood, this constitutes a firm foundation for the rational design of any barrier-related therapeutics, and it is to rationalize the role of these well-known key components of the epidermal water barrier that is the main goal of this project.
描述(申请人提供):本申请的长期目标是阐明两种脂氧合酶(LOX)酶及其必需脂肪酸(EFA)底物在形成表皮水不透水屏障中的作用,这种缺陷会导致鱼鳞病和特应性皮炎。12R-脂氧合酶(12R-LOX)和表皮脂氧合酶-3(ELOX3)是人类仅有的两种脂氧合酶,如果突变为非活性形式,会导致一种常染色体隐性遗传性先天性鱼鳞病(ARCI)。事实上,ARCI特有的鳞片状皮肤也表现为必需脂肪酸(EFA)缺乏,这表明EFA和这两种LOX酶之间可能存在底物-酶关系。我们将测试一个新的假设,连接EFA,12R-LOX和eLOX3,以及表皮水屏障的结构。我们认为,这两种脂氧合酶氧化了EFA的一种关键形式,亚油酸酯化为独特的表皮酰神经酰胺的超长链脂肪酸的欧米伽-羟基。我们进一步提出,这种氧合作用是为了促进(氧化的)亚油酸部分的水解,并使超长链脂肪酸欧米伽-羟基自由偶联到角膜细胞被膜的交联蛋白上,这是在 封堵水屏障。其具体目的是(1)利用动物模型确定活体表皮中12R-LOX和eLOX3的活性,(2)评估LOX产品和神经酰胺在挽救小鼠LOX-/-模型表型方面的有效性,(3)表征包括ARCI患者在内的人类表皮中12R-LOX和eLOX3的活性,以及(4)表征推测的酰神经酰胺酯水解氧化敏感步骤。这项研究的结果将整合构建表皮水屏障的一个重要方面,并允许合理地使用氧化亚油酸及其类似物,用于未来对LOX依赖类鱼鳞病的治疗干预。如果正确了解屏障的生理学,这将为任何屏障相关疗法的合理设计奠定坚实的基础,而本项目的主要目标是使这些众所周知的表皮水屏障关键成分的作用合理化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALAN R. BRASH其他文献

ALAN R. BRASH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALAN R. BRASH', 18)}}的其他基金

Deconstructing the lipoxygenase-hepoxilin pathway in skin barrier formation
解构皮肤屏障形成中的脂氧合酶-海泊西林途径
  • 批准号:
    10355508
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Deconstructing the lipoxygenase-hepoxilin pathway in skin barrier formation
解构皮肤屏障形成中的脂氧合酶-海泊西林途径
  • 批准号:
    10582061
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Deconstructing the lipoxygenase-hepoxilin pathway in skin barrier formation
解构皮肤屏障形成中的脂氧合酶-海泊西林途径
  • 批准号:
    10576839
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Receptor-mediated signaling pathways leading to phosphatidic acid generation
导致磷脂酸生成的受体介导的信号通路
  • 批准号:
    9218361
  • 财政年份:
    2017
  • 资助金额:
    $ 35.1万
  • 项目类别:
Novel Catalases and their Products
新型过氧化氢酶及其产品
  • 批准号:
    8450914
  • 财政年份:
    2006
  • 资助金额:
    $ 35.1万
  • 项目类别:
Novel Catalases and their Products
新型过氧化氢酶及其产品
  • 批准号:
    7886436
  • 财政年份:
    2006
  • 资助金额:
    $ 35.1万
  • 项目类别:
Novel Catalases and their Products
新型过氧化氢酶及其产品
  • 批准号:
    7208012
  • 财政年份:
    2006
  • 资助金额:
    $ 35.1万
  • 项目类别:
Novel Catalases and their Products
新型过氧化氢酶及其产品
  • 批准号:
    8241151
  • 财政年份:
    2006
  • 资助金额:
    $ 35.1万
  • 项目类别:
PATHWAYS TO 4-HYDROXYNONENAL
4-羟基壬烯醛的途径
  • 批准号:
    7209629
  • 财政年份:
    2006
  • 资助金额:
    $ 35.1万
  • 项目类别:
Novel Catalases and their Products
新型过氧化氢酶及其产品
  • 批准号:
    8054734
  • 财政年份:
    2006
  • 资助金额:
    $ 35.1万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 35.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了